An interventional study of Visual acuity measurement in Visual Disorder, sponsored by Central Hospital, Nancy, France. Terminated at 1 site in France. Open to participants aged 18 Months to 7 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-13.
Sponsored by Central Hospital, Nancy, France · Not applicable, Interventional, and Screening
This study aim at following a cohort of prematurely born infants at 18 months corrected age, 4 and 7 years of age. This cohort had an evaluation of visual maturation at term equivalent age (TEA) with factors associated with impaired visual maturation. (PREMAVISION-CLinicalTrials.gov ID: NCT02890251).
In this follow-up study, prematurely born infants vision will be compared to term born infants matched for postnatal age.
308 studies on the registry are indexed under Vision Disorders; 81 are open to participants now.
This study's enrollment of 37 is below the median of 66 across 211 interventional studies indexed under Vision Disorders.
Browse Vision Disorders studies →Central Hospital, Nancy, France is the lead sponsor of 778 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Visual acuity measurement in prematurely born infants included in PREMAVISION study
Diagnostic Test: Visual acuity measurement
Visual acuity measurement in term born control infants
Diagnostic Test: Visual acuity measurement
visual acuity measurement by Baby Vision cards at 18 months corrected age, by Rossano Weiss test at 4 years of age and optometric tests of Parinaud and Snellen at 7 years of age
Also known as: Measurement of cycloplegic refraction
Visual acuity measurement
Baby Vision Cards
Time frame: 18 months corrected age
Visual acuity measurement
Rossano Weiss test
Time frame: 4 years post-natal age
Visual acuity measurement
Parinaud and Snellen tests
Time frame: 7 years post-natal age
Measurement of cyclopegic refraction
Non invasive refraction measurement by autorefractometer Cycloplégie par Skiacol
Time frame: 18 months corrected age
Measurement of cyclopegic refraction
Non invasive refraction measurement by autorefractometer
Time frame: 4 years of age
Measurement of cyclopegic refraction
Non invasive refraction measurement by autorefractometer
Time frame: 7 years of age
Plan to share: No
No publications or documents are linked to this record.
This study is terminated, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Central Hospital, Nancy, France